Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemotherapy is significantly associated with disease recurrence in early-stage triple-negative breast cancer (TNBC): Preplanned correlative results from clinical trial BRE12-158

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemotherapy is significantly associated with disease recurrence in early-stage triple-negative breast cancer (TNBC): Preplanned correlative results from clinical trial BRE12-158

【24h】

Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemotherapy is significantly associated with disease recurrence in early-stage triple-negative breast cancer (TNBC): Preplanned correlative results from clinical trial BRE12-158

机译：循环肿瘤DNA（CTDNA）在新辅助化疗后的循环肿瘤DNA（CTDNA）与早期三重阴性乳腺癌（TNBC）的疾病复发显着相关：临床试验的预先生相关结果BRE12-158

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共3页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献
中文文献
专利

1. Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemotherapy is significantly associated with disease recurrence in early-stage triple-negative breast cancer (TNBC): Preplanned correlative results from clinical trial BRE12-158 [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：循环肿瘤DNA（CTDNA）在新辅助化疗后的循环肿瘤DNA（CTDNA）与早期三重阴性乳腺癌（TNBC）的疾病复发显着相关：临床试验的预先生相关结果BRE12-158
2. Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy [J] . Yu-Hsiang Chen, Bradley A. Hancock, Jeffrey P. Solzak, NPJ breast cancer. . 2017,第1期

机译：新一代循环肿瘤DNA测序可预测三阴性乳腺癌新辅助化疗后残留病患者的复发
3. Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer [J] . Adrien Saliou, Alexandre Houy, Anne Vincent-Salomon, Clinical Chemistry: Journal of the American Association for Clinical Chemists . 2017,第3期

机译：三阴性乳腺癌新辅助化疗期间患者特异性循环肿瘤DNA检测
4. Deep learning predicts breast cancer recurrence in analysis of consecutive MRIs acquired during the course of neoadjuvant chemotherapy [C] . Karen Drukker, Alexandra Edwards, John Papaioannou, Medical Imaging Conference . 2020

机译：深度学习通过在新辅助化疗过程中获得的连续MRI分析来预测乳腺癌的复发
5. Supportive Care for Patients with Breast Cancer by Using an Interactive App During Neoadjuvant Chemotherapy: A Randomized Controlled Trial [D] . Fjell, Maria. 2021

机译：通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理：随机对照试验
6. Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy [O] . Yu-Hsiang Chen, Bradley A. Hancock, Jeffrey P. Solzak, 2017

机译：循环肿瘤DNA的下一代测序可预测新辅助化疗后残留病的三阴性乳腺癌患者的复发
7. Relationship between tumor infiltrating lymphocytes (TILs) and response to pembrolizumab (pembro)+chemotherapy (CT) as neoadjuvant treatment (NAT) for triple-negative breast cancer (TNBC): Phase Ib KEYNOTE-173 trial [O] . S. Loi, P. Schmid, G. Aktan, 2019

机译：肿瘤浸润淋巴细胞（TIL）与PEMBLIZUMAB（PEMBRO）+化疗（CT）作为新辅助乳腺癌（TNBC）的响应（TNBC）的关系（TNBC）：第IB次临时 - 173试验

Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemotherapy is significantly associated with disease recurrence in early-stage triple-negative breast cancer (TNBC): Preplanned correlative results from clinical trial BRE12-158

著录项

相似文献

相关主题

期刊订阅